請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23279完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 鍾國彪 | |
| dc.contributor.author | Tsung-Tai Chen | en |
| dc.contributor.author | 陳宗泰 | zh_TW |
| dc.date.accessioned | 2021-06-08T04:51:21Z | - |
| dc.date.copyright | 2009-09-16 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-07-27 | |
| dc.identifier.citation | 1. Rowena J, Maria G. How do Performance Indicators Add Up? An Examination of Composite Indicators in Public Services. Public Money & Management 2007;27:103-10.
2. Christopher H. Public Service Management by Numbers: Why Does it Vary? Where Has it Come From? What Are the Gaps and the Puzzles? Public Money & Management 2007;27:95-102. 3. Teixeira-Pinto A, Normand SL. Statistical methodology for classifying units on the basis of multiple-related measures. Stat Med 2008;27:1329-50. 4. Hibbard JH, Slovic P, Peters E, Finucane ML. Strategies for reporting health plan performance information to consumers: evidence from controlled studies. Health Serv Res 2002;37:291-313. 5. Vaiana ME, McGlynn EA. What cognitive science tells us about the design of reports for consumers. Med Care Res Rev 2002;59:3-35. 6. Hibbard JH, Peters E. Supporting informed consumer health care decisions: data presentation approaches that facilitate the use of information in choice. Annu Rev Public Health 2003;24:413-33. 7. Peters E, Dieckmann N, Dixon A, Hibbard JH, Mertz CK. Less is more in presenting quality information to consumers. Med Care Res Rev 2007;64:169-90. 8. Spranca MD, Elliott MN, Shaw R, Kanouse DE. Disenrollment information and Medicare plan choice: is more information better? Health Care Financ Rev 2007;28:47-59. 9. Centers for Medicare & Medicaid Services. Hospital Quality Incentive Demonstration. (Cited 2007 Mar 4). Available from: URL: http://www.premierinc.com/quality-safety/tools-services/p4p/hqi/index.jsp. 10. CMS. U.S. Department of Health and Human Services Medicare Hospital Value-Based purchasing:Options paper. (cited 2007 Nov 4). Available from: http://www.cms.hhs.gov/AcuteInpatientPPS/downloads/HospitalVBPOptions.pdf. 11. Canice P. The provision of incentives in firms. Journal of Economic Literature 1999;37:7. 12. Rosenthal MB, Frank RG. What is the empirical basis for paying for quality in health care? Med Care Res Rev 2006;63:135-57. 13. Institute of Medicine (U.S.). Committee on Redesigning Health Insurance Performance Measures Payment and Performance Improvement Programs. Rewarding provider performance : aligning incentives in Medicare. Washington, DC: National Academies Press,2007. 14. AHRQ. AHRQ Quality Indicators Patient Safety Indicators (PSI) Composite Measure.(Cited 2009 May 30). Available from: URL: http://www.qualityindicators.ahrq.gov/news/AHRQ_PSI_Composite_Draft.pdf. 15. Kirk SA, Campbell SM, Kennell-Webb S, Reeves D, Roland MO, Marshall MN. Assessing the quality of care of multiple conditions in general practice: practical and methodological problems. Quality & safety in health care 2003;12:421-7. 16. Timbie JW, Normand SL. A comparison of methods for combining quality and efficiency performance measures: Profiling the value of hospital care following acute myocardial infarction. Stat Med 2007;27:1351-70. 17. Reeves D, Campbell SM, Adams J, Shekelle PG, Kontopantelis E, Roland MO. Combining multiple indicators of clinical quality: an evaluation of different analytic approaches. Med Care 2007;45:489-96. 18. Aron D, Rajan M, Pogach LM. Summary measures of quality of diabetes care: comparison of continuous weighted performance measurement and dichotomous thresholds. Int J Qual Health Care 2007;19:29-36. 19. Jacobs R, Goddard M, Smith PC. How robust are hospital ranks based on composite performance measures? Medical care 2005;43:1177-84. 20. O'Brien SM, DeLong ER, Dokholyan RS, Edwards FH, Peterson ED. Exploring the behavior of hospital composite performance measures: an example from coronary artery bypass surgery. Circulation 2007;116:2969-75. 21. Millenson ML. Demanding medical excellence : doctors and accountability in the information age. Chicago, Ill.: University of Chicago Press,1997. 22. Millenson ML. Pay for performance: the best worst choice. Quality & safety in health care 2004;13:323-4. 23. Rosenthal MB, Fernandopulle R, Song HR, Landon B. Paying for quality: providers' incentives for quality improvement. Health Aff (Millwood) 2004;23:127-41. 24. American HealthWays. Outcomes-Based Compensation: Pay-for-Performance Design Principles. (Cited 2007 Feb 28). Available from: URL: www.healthleadersmedia.com/pdf/white_papers/wp_AmHealthways_060105.pdf. 25. Galvin RS, Delbanco S, Milstein A, Belden G. Has the leapfrog group had an impact on the health care market? Health Aff (Millwood) 2005;24:228-33. 26. Charles NKI, Ault. T, Isenstein. H, Potetz. L, Susan VG. Snapshot Of Hospital Quality Reporting And Pay-For-Performance Under Medicare. Health Aff (Millwood) 2006;25:148-62. 27. Shekelle P. New contract for general practitioners. Bmj 2003;326:457-8. 28. Birkmeyer NJ, Birkmeyer JD. Strategies for improving surgical quality--should payers reward excellence or effort? N Engl J Med 2006;354:864-70. 29. Anderson G, Horvath J. The growing burden of chronic disease in America. Public Health Rep 2004;119:263-70. 30. Pink GH, Brown AD, Studer ML, Reiter KL, Leatt P. The authors respond. Healthc Pap 2006;6:72-4. 31. Rand. Rand:The First National Report Card on Quality of Health Care in America. (cited 2006 Oct 24). Available from: URL: http://www.rand.org/pubs/research_briefs/RB9053-2/index1.html. 32. Hibbard JH, Peters E, Dixon A, Tusler M. Consumer Competencies and the Use of Comparative Quality Information: It Isn't Just about Literacy. Med Care Res Rev 2007;64:379-94. 33. Institute of Medicine (U.S.). Committee on Quality of Health Care in America. Crossing the quality chasm : a new health system for the 21st century. Washington, D.C.: National Academy Press,2001. 34. Robinson JC. Theory and practice in the design of physician payment incentives. The Milbank quarterly 2001;79:149-77, III. 35. Galvin RS, Delbanco S, Milstein A, Belden G. Has the leapfrog group had an impact on the health care market? Health Affairs 2005;24:228-33. 36. Rosenau PV, Lako CJ. An experiment with regulated competition and individual mandates for universal health care: the new Dutch health insurance system. Journal of health politics, policy and law 2008;33:1031-55. 37. McNiel DE, Binder RL. Effectiveness of a mental health court in reducing criminal recidivism and violence. The American journal of psychiatry 2007;164:1395-403. 38. Centers for Medicare & Medicaid Services: Medicare Physician Group Practice Demonstration. (Cited 2007 Feb 28). Available from: URL: http://www.cms.hhs.gov/DemoProjectsEvalRpts/MD/itemdetail.asp?filterType=none&filterByDID=-99&sortByDID=3&sortOrder=ascending&itemID=CMS024227. 39. Kautter J, Pope GC, Trisolini M, Grund S. Medicare physician group practice demonstration design: quality and efficiency pay-for-performance. Health care financing review 2008;29:15-29. 40. Christianson JB. Evaluating pay-for-performance in medicaid through real-world observation. Health affairs (Project Hope) 2007;26:w528-31. 41. Felt-Lisk S, Gimm G, Peterson S. Making pay-for-performance work in Medicaid. Health affairs (Project Hope) 2007;26:w516-27. 42. Solomon DH, Gabriel SE. Moving forward with quality: pay for reporting meets rheumatology. Arthritis Rheum 2007;57:703-4. 43. QualityNet. Reporting Hospital Quality Data for Annual Payment Update. (cited 2007 Nov 4). Available from: http://qualitynet.org/dcs/ContentServer?cid=1138115987129&pagename=QnetPublic%2FPage%2FQnetTier2&c=Page. 44. Normand SL, Wolf RE, McNeil BJ. Discriminating quality of hospital care in the United States. Med Decis Making 2008;28:308-22. 45. Berry DA. Bayesian statistics. Med Decis Making 2006;26:429-30. 46. Frayne SM, Halanych JH, Miller DR, et al. Disparities in diabetes care: impact of mental illness. Archives of internal medicine 2005;165:2631-8. 47. Young GJ, White B, Burgess JF, Jr., et al. Conceptual issues in the design and implementation of pay-for-quality programs. Am J Med Qual 2005;20:144-50. 48. Rosenfeld S, Zeitler E, Mendelson D. Intergrated Healthcare Association. Advancing quality through collaboration:the california pay for performance program. (Cited 2006 June 17). Available from: URL: http://www.iha.org/wp020606.pdf. 49. Prometheus. Bridges to Excellence. (cited 2007 Mar 7). Available from: URL: http://bridgestoexcellence.org/wp_prometheus.htm 50. Blue Cross and Blue Shield of Michigan. (cited 2007 Mar 7). Available from: URL: http://www.bcbsm.com/. 51. Excellus. (cited 2007 Mar 7). Available from URL: https://www.excellusbcbs.com/. 52. British Medical Association(a). Investing in general practice - the new general medical services contract Chapter 3. (Cited 2006 June 13). Available from: URL: http://www.bma.org.uk/ap.nsf/Content/investinggp~chap3. 53. British Medical Association(b). Revisions to the GMS contract 2006/07. (Cited 2006 June 26). Available from: URL: http://www.bma.org.uk/ap.nsf/Content/revisionnGMSFeb20062. 54. Cho SH. Using multilevel analysis in patient and organizational outcomes research. Nursing research 2003;52:61-5. 55. Scott IA. Pay for performance in health care: strategic issues for Australian experiments. Med J Aust 2007;187:31-5. 56. David AH, Mark BG. Centering decisions in hierarchical linear models: Implications for research in organizations. Journal of Management 1998;24:623. 57. Gross R, Elhaynay A, Friedman N, Buetow S. Pay-for-performance programs in P4P programs Israeli sick funds. Journal of health organization and management 2008;22:23-35. 58. Buetow S. Pay-for-performance in New Zealand primary health care. Journal of health organization and management 2008;22:36-47. 59. Perkins R, Seddon M. Quality improvement in New Zealand healthcare. Part 5: measurement for monitoring and controlling performance--the quest for external accountability. N Z Med J 2006;119:U2149. 60. American. Medical Association. Principals for Pay-for-Performance Programs. (Cited 2007 Feb 28). Available from: URL: www.ama-assn.org/ama1/pub/upload/mm/-1/finalpfpprinciples.pdf 61. American. Medical Association. Guidelines for Pay-for-Performance Programs. (Cited 2007 Feb 28). Available from: URL: www.ama-assn.org/ama1/pub/upload/mm/368/guidelines4pay62705.pdf. 62. Hung JH, Chang L. Has cost containment after the National Health Insurance system been successful? Determinants of Taiwan hospital costs. Health policy (Amsterdam, Netherlands) 2008;85:321-35. 63. HJ Chang.Quality-Based Payment -Taiwan's Experience. (Cited 2007 July 10). Available from: URL: http://www.academyhealth.org/2004/chang3.pdf. 64. YS Li. The Effects of Pay-for-Performance System on Tuberculosis Control & Treatment in Taiwan. (Cited 2007 July 16). Available from: URL: http://www.academyhealth.org/2007/sunday/australia3/li.ppt. 65. Mainz J. Developing evidence-based clinical indicators: a state of the art methods primer. Int J Qual Health Care 2003;15 Suppl 1:i5-11. 66. Conrad DA, Christianson JB. Penetrating the 'black box': financial incentives for enhancing the quality of physician services. Med Care Res Rev 2004;61:37S-68S. 67. Leatherman S, Berwick D, Iles D, et al. The business case for quality: case studies and an analysis. Health Aff (Millwood) 2003;22:17-30. 68. Kindig DA. Purchasing population health: aligning financial incentives to improve health outcomes. Health Serv Res 1998;33:223-42. 69. Kindig DA. Purchasing population health: aligning financial incentives to improve health outcomes. Nurs Outlook 1999;47:15-22. 70. Town R, Kane R, Johnson P, Butler M. Economic incentives and physicians' delivery of preventive care: a systematic review. Am J Prev Med 2005;28:234-40. 71. Rosenthal MB, Landon BE, Normand SL, Frank RG, Ahmad TS, Epstein AM. Employers' use of value-based purchasing strategies. Jama 2007;298:2281-8. 72. Sigfrid LA, Turner C, Crook D, Ray S. Using the UK primary care Quality and Outcomes Framework to audit health care equity: preliminary data on diabetes management. Journal of public health (Oxford, England) 2006;28:221-5. 73. Rosenthal MB, Frank RG, Li Z, Epstein AM. Early experience with pay-for-performance: from concept to practice. Jama 2005;294:1788-93. 74. Gilmore AS, Zhao Y, Kang N, et al. Patient outcomes and evidence-based medicine in a preferred provider organization setting: a six-year evaluation of a physician pay-for-performance program. Health Serv Res 2007;42:2140-59; discussion 294-323. 75. Levin-Scherz J, DeVita N, Timbie J. Impact of pay-for-performance contracts and network registry on diabetes and asthma HEDIS measures in an integrated delivery network. Med Care Res Rev 2006;63:14S-28S. 76. Glickman SW, Ou FS, DeLong ER, et al. Pay for performance, quality of care, and outcomes in acute myocardial infarction. Jama 2007;297:2373-80. 77. Lindenauer PK, Remus D, Roman S, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med 2007;356:486-96. 78. Pearson SD, Schneider EC, Kleinman KP, Coltin KL, Singer JA. The impact of pay-for-performance on health care quality in Massachusetts, 2001-2003. Health affairs (Project Hope) 2008;27:1167-76. 79. Hanley JA, Negassa A, Edwardes MD, Forrester JE. Statistical analysis of correlated data using generalized estimating equations: an orientation. American journal of epidemiology 2003;157:364-75. 80. Campbell S, Reeves D, Kontopantelis E, Middleton E, Sibbald B, Roland M. Quality of primary care in England with the introduction of pay for performance. N Engl J Med 2007;357:181-90. 81. Bratzler DW, Nsa W, Houck PM. Performance measures for pneumonia: are they valuable, and are process measures adequate? Current opinion in infectious diseases 2007;20:182-9. 82. Young GJ, Meterko M, Beckman H, et al. Effects of paying physicians based on their relative performance for quality. J Gen Intern Med 2007;22:872-6. 83. Christianson, J., S. Leatherman, and K. Sutherland. 2008. Financial Incentives, Healthcare Providers and Quality Improvements. London: Health Foundation. 84. Petersen LA, Woodard LD, Urech T, Daw C, Sookanan S. Does pay-for-performance improve the quality of health care? Annals of internal medicine 2006;145:265-72. 85. Fleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Parrott MA. The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes care 2001;24:1815-20. 86. McDonald R, Harrison S, Checkland K, Campbell SM, Roland M. Impact of financial incentives on clinical autonomy and internal motivation in primary care: ethnographic study. Bmj 2007;334:1357. 87. Nahra TA, Reiter KL, Hirth RA, Shermer JE, Wheeler JR. Cost-effectiveness of hospital pay-for-performance incentives. Med Care Res Rev 2006;63:49S-72S. 88. Curtin K, Beckman H, Pankow G, Milillo Y, Green RA. Return on investment in pay for performance: a diabetes case study. J Healthc Manag 2006;51:365-74; discussion 75-6. 89. Roland M. Pay-for-performance: too much of a good thing? A conversation with Martin Roland. Interview by Robert Galvin. Health Aff (Millwood) 2006;25:w412-9. 90. Leatherman S, Berwick D, Iles D, et al. The business case for quality: case studies and an analysis. Health Affairs 2003;22:17-30. 91. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003;348:2635-45. 92. Kilpatrick KE, Lohr KN, Leatherman S, et al. The insufficiency of evidence to establish the business case for quality. Int J Qual Health Care 2005;17:347-55. 93. Teleki SS, Damberg CL, Pham C, Berry SH. Will financial incentives stimulate quality improvement? Reactions from frontline physicians. Am J Med Qual 2006;21:367-74. 94. Young GJ, Meterko M, White B, et al. Physician attitudes toward pay-for-quality programs: perspectives from the front line. Med Care Res Rev 2007;64:331-43. 95. Casalino LP, Alexander GC, Jin L, Konetzka RT. General internists' views on pay-for-performance and public reporting of quality scores: a national survey. Health Aff (Millwood) 2007;26:492-9. 96. Bokhour BG, Burgess JF, Jr., Hook JM, et al. Incentive implementation in physician practices: A qualitative study of practice executive perspectives on pay for performance. Med Care Res Rev 2006;63:73S-95S. 97. Beckman H, Suchman AL, Curtin K, Greene RA. Physician reactions to quantitative individual performance reports. Am J Med Qual 2006;21:192-9. 98. Meterko M, Young GJ, White B, et al. Provider attitudes toward pay-for-performance programs: development and validation of a measurement instrument. Health Serv Res 2006;41:1959-78. 99. Strong M, Maheswaran R, Radford J. Socioeconomic deprivation, coronary heart disease prevalence and quality of care: a practice-level analysis in Rotherham using data from the new UK general practitioner Quality and Outcomes Framework. Journal of public health (Oxford, England) 2006;28:39-42. 100. Ashworth M, Seed P, Armstrong D, Durbaba S, Jones R. The relationship between social deprivation and the quality of primary care: a national survey using indicators from the UK Quality and Outcomes Framework. Br J Gen Pract 2007;57:441-8. 101. Doran T, Fullwood C, Gravelle H, et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med 2006;355:375-84. 102. McLean G, Sutton M, Guthrie B. Deprivation and quality of primary care services: evidence for persistence of the inverse care law from the UK Quality and Outcomes Framework. J Epidemiol Community Health 2006;60:917-22. 103. Gray J, Millett C, Saxena S, Netuveli G, Khunti K, Majeed A. Ethnicity and quality of diabetes care in a health system with universal coverage: population-based cross-sectional survey in primary care. J Gen Intern Med 2007;22:1317-20. 104. Chien AT, Chin MH, Davis AM, Casalino LP. Pay for performance, public reporting, and racial disparities in health care: how are programs being designed? Med Care Res Rev 2007;64:283S-304S. 105. Pham HH, Schrag D, O'Malley AS, Wu B, Bach PB. Care patterns in Medicare and their implications for pay for performance. N Engl J Med 2007;356:1130-9. 106. Turenne MN, Hirth RA, Pan Q, Wolfe RA, Messana JM, Wheeler JR. Using Knowledge of Multiple Levels of Variation in Care to Target Performance Incentives to Providers. Med Care 2008;46:120-6. 107. Gestur D, Ira M, Denise R. Hospital Size, Uncertainty, and Pay-for-Performance. Health Care Financing Review 2007;29:45. 108. Martin D, Wright JA. Disease prevalence in the English population: A comparison of primary care registers and prevalence models. Social science & medicine (1982) 2008. 109. Schmittdiel J, Vijan S, Fireman B, Lafata JE, Oestreicher N, Selby JV. Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control. Medical care 2007;45:315-21. 110. O'Brien SM, Shahian DM, DeLong ER, et al. Quality measurement in adult cardiac surgery: part 2--Statistical considerations in composite measure scoring and provider rating. The Annals of thoracic surgery 2007;83:S13-26. 111. Hermansa E, Bosscheb FVd, Wets G. Combining road safety information in a performance index. Accident Analysis and Prevention 2008;40:1337-44. 112. Shwartz M, Ren J, Pekoz EA, Wang X, Cohen AB, Restuccia JD. Estimating a composite measure of hospital quality from the Hospital Compare database: differences when using a Bayesian hierarchical latent variable model versus denominator-based weights. Medical care 2008;46:778-85. 113. Jha AK, Li Z, Orav EJ, Epstein AM. Care in U.S. hospitals--the Hospital Quality Alliance program. N Engl J Med 2005;353:265-74. 114. Institute of Medicine (U.S.). Committee on Redesigning Health Insurance Performance Measures Payment and Performance Improvement Programs. Performance measurement : accelerating improvement. Washington, D.C.: National Academies Press,2006. 115. Nolan T, Berwick DM. All-or-none measurement raises the bar on performance. Jama 2006;295:1168-70. 116. Campbell SM, Roland MO, Middleton E, Reeves D. Improvements in quality of clinical care in English general practice 1998-2003: longitudinal observational study. Bmj 2005;331:1121. 117. Lieberthal RD. Hospital quality: a PRIDIT approach. Health services research 2008;43:988-1005. 118. Bross, I. DJ. How to Use Ridit Analysis. Biometrics 1958;14:18–38. 119. Campbell SM, Hann M, Hacker J, et al. Identifying predictors of high quality care in English general practice: observational study. BMJ 2001;323:784-7. 120. Landrum MB, Bronskill SE, Normand S-L. Analytic methods for constructing cross-sectional profiles of health care providers. Heal Serv Out Res Meth. 2000;1:23– 47. 121. Staiger DO, Dimick JB, Baser O, Fan Z, Birkmeyer JD. Empirically derived composite measures of surgical performance. Medical care 2009;47:226-33. 122. Timmins N. Do GPs deserve their recent pay rise? Bmj 2005;331:800. 123. Hays RD, Morales LS, Reise SP. Item response theory and health outcomes measurement in the 21st century. Medical care 2000;38:II28-42. 124. Gardner W, Kelleher KJ, Pajer KA. Multidimensional adaptive testing for mental health problems in primary care. Medical care 2002;40:812-23. 125. Steven BC, Mercedes A, Montserrat G. Fraud detection using a multinomial logit model with missing information. Journal of Risk and Insurance 2005;72:539. 126. Kerr EA, Smith DM, Hogan MM, et al. Building a better quality measure: are some patients with 'poor quality' actually getting good care? Medical care 2003;41:1173-82. 127. Werner RM, Bradlow ET. Relationship between Medicare's hospital compare performance measures and mortality rates. Jama 2006;296:2694-702. 128. Bradley EH, Herrin J, Elbel B, et al. Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. Jama 2006;296:72-8. 129. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. Jama 2002;287:2542-51. 130. Landon BE, Normand SL, Blumenthal D, Daley J. Physician clinical performance assessment: prospects and barriers. Jama 2003;290:1183-9. 131. Kerr EA, Krein SL, Vijan S, Hofer TP, Hayward RA. Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of technical quality measures. Am J Manag Care 2001;7:1033-43. 132. Dimick JB, Welch HG, Birkmeyer JD. Surgical mortality as an indicator of hospital quality: the problem with small sample size. Jama 2004;292:847-51. 133. O'Brien SM, Delong ER, Peterson ED. Impact of case volume on hospital performance assessment. Archives of internal medicine 2008;168:1277-84. 134. Drye EE, Chen J. Evaluating quality in small-volume hospitals. Archives of internal medicine 2008;168:1249-51. 135. Dimick JB, Welch HG. The zero mortality paradox in surgery. Journal of the American College of Surgeons 2008;206:13-6. 136. Hospital Compare Web site. http://www.hospitalcompare.hhs.gov. Accessed November 23, 2008. 137. Scholle SH, Roski J, Adams JL, et al. Benchmarking physician performance: reliability of individual and composite measures. The American journal of managed care 2008;14:833-8. 138. Kiefe CI, Weissman NW, Allison JJ, Farmer R, Weaver M, Williams OD. Identifying achievable benchmarks of care: concepts and methodology. Int J Qual Health Care 1998;10:443-7. 139. Michael Freudenberg, 2003. 'Composite Indicators of Country Performance: A Critical Assessment,' OECD Science, Technology and Industry Working Papers 2003/16, OECD Directorate for Science, Technology and Industry. 140. Klebanoff MA, Cole SR. Use of multiple imputation in the epidemiologic literature. American journal of epidemiology 2008;168:355-7. 141. Yang C. Yuan (2002) Multiple Imputation for Missing Data:Concepts and New Development, SAS Institute. Inc., Rockeville, MD. 142. Krumholz HM, Rathore SS, Chen J, Wang Y, Radford MJ. Evaluation of a consumer-oriented internet health care report card: the risk of quality ratings based on mortality data. Jama 2002;287:1277-87. 143. Greenfield S, Kaplan SH, Kahn R, Ninomiya J, Griffith JL. Profiling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results. Annals of internal medicine 2002;136:111-21. 144. Krein SL, Hofer TP, Kerr EA, Hayward RA. Whom should we profile? Examining diabetes care practice variation among primary care providers, provider groups, and health care facilities. Health services research 2002;37:1159-80. 145. Hofer TP, Hayward RA, Greenfield S, Wagner EH, Kaplan SH, Manning WG. The unreliability of individual physician 'report cards' for assessing the costs and quality of care of a chronic disease. Jama 1999;281:2098-105. 146. Milgate K, Cheng SB. Pay-for-performance: the MedPAC perspective. Health Aff (Millwood) 2006;25:413-9. 147. Silber JH, Rosenbaum PR, Ross RN. Comparing the contributions of groups of predictors: Which outcomes vary with hospital rather than patient characteristics? Journal of the American Statistical Association 1995;90:7. 148. Ahmann AJ. Guidelines and performance measures for diabetes. The American journal of managed care 2007;13 Suppl 2:S41-6. 149. DQIP measures now put providers on same page in gauging quality diabetes care. Diabetes Quality Improvement Project. The Quality letter for healthcare leaders 2000;12:10-2. 150. National Diabetes Quality Improvement Alliance. Performance measurement set for adult diabetes. Approved January 21, 2005. Available at: http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?doc_id=4065. Accessed Dec 27, 2008. 151. Cheng AY, Leiter LA. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Current opinion in cardiology 2006;21:400-4. 152. Standards of medical care in diabetes--2008. Diabetes care 2008;31 Suppl 1:S12-54. 153. American College of Endocrinology and American Diabetes Association Consensus statement on inpatient diabetes and glycemic control. Diabetes care 2006;29:1955-62. 154. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86. 155. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53. 156. Voorham J, Denig P, Wolffenbuttel BH, Haaijer-Ruskamp FM. Cross-sectional versus sequential quality indicators of risk factor management in patients with type 2 diabetes. Medical care 2008;46:133-41. 157. Timbie JW, Newhouse JP, Rosenthal MB, Normand SL. A cost-effectiveness framework for profiling the value of hospital care. Med Decis Making 2008;28:419-34. 158. Vitikainen K, Street A, Linna M. Estimation of hospital efficiency-Do different definitions and casemix measures for hospital output affect the results? Health policy 2008;89:149-59 159. Masiye F, Kirigia JM, Emrouznejad A, et al. Efficient management of health centres human resources in Zambia. Journal of medical systems 2006;30:473-81. 160. Rosko MD, Mutter RL. Stochastic frontier analysis of hospital inefficiency: a review of empirical issues and an assessment of robustness. Med Care Res Rev 2008;65:131-66. 161. Timonthy J Coelli, Rao; DSP, O'Donnell; CJ, Battese GE, eds. an introduction to efficiency and productivity analysis: Springer; 2005. 162. Thomas JW. Should episode-based economic profiles be risk adjusted to account for differences in patients' health risks? Health services research 2006;41:581-98. 163. Hargraves JL, Hays RD, Cleary PD. Psychometric properties of the Consumer Assessment of Health Plans Study (CAHPS) 2.0 adult core survey. Health services research 2003;38:1509-27. 164. Quigley DD, Elliott MN, Hays RD, Klein DJ, Farley DO. Bridging From the Picker Hospital Survey to the CAHPS Hospital Survey. Medical care 2008;46:654-61. 165. SAS Institute Inc. SAS/STAT 9.1 User's Guide. Cary, NC: SAS Institute Inc; 2004. 166. Hearnshaw H, Lindenmeyer A. What do we mean by adherence to treatment and advice for living with diabetes? A review of the literature on definitions and measurements. Diabet Med 2006;23:720-8. 167. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Medical care 2008;46:1125-33. 168. National Committee for Quality Assurance, American Diabetes Association. Diabetes Physician Recognition Program (DPRP). Available at: http://www.ncqa.org/tabid/139/Default.aspx Accessed Dec 27, 2008. 169. Kaplan SH, Griffith JL, Price LL, Pawlson LG, Greenfield S. Improving the reliability of physician performance assessment: identifying the 'physician effect' on quality and creating composite measures. Medical care 2009;47:378-87. 170. Standards of medical care for patients with diabetes mellitus. Diabetes care 2002;25:213-29. 171. Pogach LM, Rajan M, Aron DC. Comparison of weighted performance measurement and dichotomous thresholds for glycemic control in the Veterans Health Administration. Diabetes care 2006;29:241-6. 172. Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. Journal of the Formosan Medical Association = Taiwan yi zhi 2005;104:157-63. 173. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes care 2002;25:512-6. 174. Lu FH, Yang YC, Wu JS, Wu CH, Chang CJ. A population-based study of the prevalence and associated factors of diabetes mellitus in southern Taiwan. Diabet Med 1998;15:564-72. 175. Petersen LA, Woodard LD, Henderson LM, Urech TH, Pietz K. Will hypertension performance measures used for pay-for-performance programs penalize those who care for medically complex patients? Circulation 2009;119:2978-85. 176. Pogach LM, Tiwari A, Maney M, Rajan M, Miller DR, Aron D. Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control? The American journal of managed care 2007;13:133-40. 177. Bynum JP, Bernal-Delgado E, Gottlieb D, Fisher E. Assigning ambulatory patients and their physicians to hospitals: a method for obtaining population-based provider performance measurements. Health services research 2007;42:45-62. 178. Kautter, J., Pope, G.C., Trisolini, M., et al.: Physician Group Evaluation First Evaluation Report. Final Report to the Centers for Medicare & Medicaid Services under Contract Number 500000024 (TO13). RTI International. Waltham, MA. June 2006. 179. Zhang Q, Safford M, Ottenweller J, et al. Performance status of health care facilities changes with risk adjustment of HbA1c. Diabetes Care 2000;23:919-27. 180. Thompson W, Wang H, Xie M, et al. Assessing quality of diabetes care by measuring longitudinal changes in hemoglobin A1c in the Veterans Health Administration. Health Serv Res 2005;40:1818-35. 181. Huang IC, Dominici F, Frangakis C, Diette GB, Damberg CL, Wu AW. Is risk-adjustor selection more important than statistical approach for provider profiling? Asthma as an example. Med Decis Making 2005;25:20-34. 182. Helmer DA, Tseng CL, Brimacombe M, Rajan M, Stiptzarov N, Pogach L. Applying diabetes-related Prevention Quality Indicators to a national cohort of veterans with diabetes. Diabetes care 2003;26:3017-23. 183. Meduru P, Helmer D, Rajan M, Tseng CL, Pogach L, Sambamoorthi U. Chronic illness with complex | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/23279 | - |
| dc.description.abstract | 背景: 隨著越來越多的論成效計酬和品質報告卡計畫在世界推行,醫療政策專家對於醫療機構的排名和組合分數(composite score)的議題感到有興趣並且有一些爭議出現。雖然一些研究已經討論過組合分數,但是仍然很少的實證研究利用組合分數及全國的資料庫來探討論成效計酬(P4P)下的醫院排名。簡單來說,我們仍然不清楚選擇組合分數的方法不同是否會對P4P的醫院排名有重大影響,特別是在組合分數包含有風險校正的結果指標時。而且每一個組合分數方法的不確定性(信度)和效度也很少一起在文獻中做比較。同時,小樣本醫院的問題,風險校正和課責制度(accountability)的議題也需要在建構組合分數一起考量。
目的:我們使用全國的資料來建構及實証糖尿病論成效計酬的潛在分數(包括兩個項目反應理論的模式及PRIDIT模式)和非潛在分數(包括原始分數加總、全有或全無分數及品質積存人年分數)。根據這些結果,我們摘要出潛在和非潛在分數的重要特性(例如加權機制),並且做出如何與論成效計酬誘因設計的結構面配套的建議。 方法與材料:參加加成方案的糖尿病人除了需符合ICD碼250之外,還需在2007年就診4次及大於18歲,最後經過最大量演算法(plurality algorithm)以歸類給特定醫師。資料從中央健保局2005年1月至2007年12月的保險資料來。糖尿病的結果資料,例如糖化血色素的值,從中央健保局為醫療院所自行申報病人結果而設立的虛擬私人網路(Virtual Private Network,VPN)來。本研究為橫斷性研究,首先利用GEE模式校正糖化血色素的值,接者再運用不同的演算法計算出組合分數,然後用醫療機構排序的一致性、效度和信度等準則來比較不同的P4P組合分數。我們亦提供敏感度分析的結果以避免小醫療機構的對排名的影響。 結果: 我們發覺在非潛在分數方面,原始分數加總比全有全無分數好,原因在於其具有較高的信度和效度,及與潛在分數有高相關。潛在分數又優於非潛在分數,原因在於有更高的信效度,加權機制和豐富的政策意涵。其中,PRIDIT模式的效度優於所有的項目反應理論的模式,但是在信度方面卻相反。 結論: 我們整合了必要的元素以讓我們的組合分數研究更嚴謹,像是風險校正,最大量演算法(為了分配病人給一個醫師)和敏感度分析。我們也提出了如何在適當的時機點根據不同的潛在分數方法來做應用,以及如何與P4P的誘因結構做搭配。 | zh_TW |
| dc.description.abstract | Background:
With more and more P4P and public disclosure initiatives been established around the world, health care experts showed their interests in and debate on the facility rankings and composite score issues. Although some research had discussed about a composite score, there are still little empirical testing about exploring the hospital ranking differences using a P4P composite score and nationwide database. In brief, we still don’t clearly understand whether the choice of methodology will have larger impact on P4P hospital rankings based on composite score, especially when it consists of the risk-adjusted outcome measures. And the degree of uncertainty (reliability) and validity of every composite score method is also less compared in literature. For constructing composite score, the problems of small-volume facilities, and the issue of risk adjustment and accountability are needed also to work with the composite score. Objectives: We constructed and proved the characteristics of DM (Diabetes Mellitus) P4P latent score (including two IRT-based Models and PRIDIT Model) and non-latent score (including raw sum score, all-or-none score, QALYs saved score). According to the results, we summarized the important characteristics of latent and non-latent composite score (e.g. weighting mechanism), and made suggestions that how to supplement them to the structure aspect of P4P incentive design. Methods and Materials: Not only DM patients with age > 18 participating in P4P Add-On Program must had ICD 250 code, but also they had at least four numbers of visits in year 2007. Then, they were assigned to one specific physician through plurality algorithm (accountability). DM P4P data were collected from the regular claim data of Bureau of National Health Insurance (NHI) for the period January 2005 to December 2007. DM patient outcome data, such as A1C values were retrieved from the Virtual Private Network (VPN) sponsored by NHI for the facilities or clinics self-reporting patients’ outcome. This research is a cross-sectional study. We first adjusted A1C level using GEE model then calculated composite scores using different algorithms. Then, comparison of different methods of P4P composite score were by three criteria, including agreement of hospital ranks, validity, and reliability. We also proposed sensitive results for avoiding the influence of small volume facilities on ranks. Results: For non-latent methods, we found that raw sum score were better than all-or-none score because of the higher validity, reliability, and higher correlation with latent score. Latent methods were superior to all of the non-latent methods because they are more excellent in validity and reliability than non-latent methods, and had specific weighting themes, as well as richer P4P policy implications. Among these latent scores, we found PRIDIT Model was superior to both IRT-based Models in validity, but opposite in reliability. Conclusion: We integrated some necessary elements into our research of composite score such as risk adjustment, use of plurality algorithm (for assigning patients to one physician), and sensitivity analysis for making our study stricter. We also proposed according their own characteristics how the appropriate timing of implementing different latent scores is, and how to supplement to the structure of P4P incentive design. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T04:51:21Z (GMT). No. of bitstreams: 1 ntu-98-D95843003-1.pdf: 715264 bytes, checksum: 3c699fda4709ca70c1d44c5ea22d61e2 (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | ABSTRACT 5
CHAPTER 1 INTRODUCTION 12 CHAPTER 2 LITERATURE REVIEW 15 2.1 INTRODUCTION TO PAY-FOR-PERFORMANCE 15 2.2 DIFFERENT ISSUES OF P4P 19 2.3 METHODS OF COMPOSITE SCORE 24 2.4 OTHERS CONSIDERATIONS RELATED TO COMPOSITE SCORE 32 2.5 DM PAY-FOR-PERFORMANCE INDICATORS AND COMPOSITE SCORES 35 CHAPTER 3 MATERIALS AND METHODS 40 3.1 DATA COLLECTION 40 3.2 DEFINITION OF THE DM PATIENTS, INDICATORS AND “PLURALITY PROVIDER ALGORITHM” 40 3.3 RISK ADJUSTED A1C LEVEL AND SMALL NUMBER OF FACILITIES 41 3.4 METHODS OF COMPOSITE SCORE 45 3.5 COMPARISON OF DIFFERENT COMPOSITE SCORE METHOD 50 CHAPTER 4 RESULTS 53 CHAPTER 5 DISCUSSION 79 5.1 ADVANTAGE OF THIS STUDY 79 5.2 STUDY FINDINGS AND INTERPRETATION 79 5.3 LIMITATION 88 CHAPTER 6 CONCLUSION AND SUGGESTION 91 6.1 CONCLUSION 91 6.2 POLICY IMPLICATIONS 91 6.3 FUTURE RESEARCH 95 REFERENCES 97 | |
| dc.language.iso | en | |
| dc.subject | 信效度 | zh_TW |
| dc.subject | 組合分數 | zh_TW |
| dc.subject | 論成效計酬 | zh_TW |
| dc.subject | 糖尿病 | zh_TW |
| dc.subject | 醫院排名 | zh_TW |
| dc.subject | pay-for-performance | en |
| dc.subject | validity and reliability | en |
| dc.subject | hospital ranking | en |
| dc.subject | Diabetes Mellitus | en |
| dc.subject | composite score | en |
| dc.title | 多重指標所製成的組織成效組合分數之發展與應用探討–以治療糖尿病論成效計酬病人的醫院排序為例 | zh_TW |
| dc.title | Development and application of a composite score comprising multiple measures for organization performance measurement – an example of hospital ranking in treating DM pay-for-performance patients | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-2 | |
| dc.description.degree | 博士 | |
| dc.contributor.coadvisor | 賴美淑 | |
| dc.contributor.oralexamcommittee | 李丞華,周穎政,黃景祥,王明鉅,鄭守夏 | |
| dc.subject.keyword | 組合分數,論成效計酬,糖尿病,醫院排名,信效度, | zh_TW |
| dc.subject.keyword | composite score,pay-for-performance,Diabetes Mellitus,hospital ranking,validity and reliability, | en |
| dc.relation.page | 108 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2009-07-27 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 醫療機構管理研究所 | zh_TW |
| 顯示於系所單位: | 健康政策與管理研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 未授權公開取用 | 698.5 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
